Kevin Patrick Moran Net Worth & Insider Trades

Kevin Patrick Moran - SVP, Vanda Pharmaceuticals Inc

As of August 1, 2022

What is Kevin Patrick Moran's Net Worth?

The current estimated net worth of Vanda Pharmaceuticals Inc's SVP, Kevin Patrick Moran, is estimated to be about $1.14M . Kevin Patrick Moran owns about 118,087 units of Vanda Pharmaceuticals Inc common stock. In the last 2 years at Vanda Pharmaceuticals Inc, Kevin Patrick Moran has sold an estimated value of $376.02K worth.

What is Kevin Patrick Moran's Past Insider Trading?

Kevin Patrick Moran's largest sale order was 9,371 units , worth over $171.97K on March 3, 2021. In total, Kevin Patrick Moran has made about 6 transactions over 2 years of their time at Vanda Pharmaceuticals Inc. Kevin Patrick Moran usually trades in March and July, with the busiest year in 2021. The most recent transaction was a sale order of 2,239 units , worth over $24.56K on August 1, 2022.

Kevin Patrick Moran

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Kevin Patrick Moran's Salary in 2020?

As SVP of Vanda Pharmaceuticals Inc, Kevin Patrick Moran has a total base salary of $324,693 . Kevin Patrick Moran received compensation valued at about $1,319,699 in 2020 after becoming SVP. The vast majority of their compensation came in the form of stock awards of $331,101 , option awards of $427,779 , other earnings, plans or compensations of $200,000 , and other compensation of $36,126 .

What is Kevin Patrick Moran's' Mailing Address?

  • Mailing address is C/o Vanda Pharmaceuticals Inc. 2200 Pennsylvania Avenue, Suite 300e Washington DC 20037 DC

Vanda Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mihael H. Polymeropoulos, M.D. 2020 $746,235 - $679,200 $795,830 $656,687 $35,468 $2,913,420
Mihael H. Polymeropoulos, M.D. 2019 $721,000 - $1,237,200 $1,610,154 $675,000 $34,783 $4,278,137
Mihael H. Polymeropoulos, M.D. 2018 $700,000 - $1,131,000 $1,456,406 $700,000 $37,322 $4,024,728
James P. Kelly 2020 $124,057 - - - - $16,217 $140,274
James P. Kelly 2019 $493,370 - $618,600 $805,077 $288,622 $42,741 $2,248,410
James P. Kelly 2018 $479,000 - $754,000 $832,232 $299,375 $36,778 $2,401,385
Kevin Moran 2020 $324,693 - $331,101 $427,779 $200,000 $36,126 $1,319,699
Joakim Wijkstrom 2020 $506,422 - $339,600 $397,915 $250,679 $29,269 $1,523,885
Aranthan "AJ" Jones II 2020 $406,104 - $339,600 $397,915 $201,021 $33,677 $1,378,317
Timothy Williams 2020 $400,000 - $339,600 $397,915 $200,000 $41,546 $1,379,061
Timothy Williams 2019 $379,315 - $618,600 $805,077 $177,520 $42,342 $2,022,854
Timothy Williams 2018 $144,886 $40,000 $643,500 $1,086,894 $71,918 $15,658 $2,002,856
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm

What are Vanda Pharmaceuticals Inc's Past Insider Trades?

Vanda Pharmaceuticals Inc's most recent insider trade came on August 23, 2022 by Joakim Wijkstrom who sold 3,605 units worth $37.01K . In the last 16 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $296.09M and bought an estimated value of $28.25M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO,  James P. Kelly, EVP & Chief Financial Officer,  and Richard W Dugan, Director .

Vanda Pharmaceuticals Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1